Clinical Trials
45 trialsComparison of CT and MR (VI-RADS) Imaging for Local Bladder Cancer Staging
Oslo University Hospital
CISTO
University of Washington
Nova-sTAR
Janssen Research & Development, LLC
TVNIM-AFU
Association Francaise d'Urologie
Follow up of Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive Bladder Cancer (NMIBC)
ImmunityBio, Inc.
CISTO2
University of Washington
Tumor Budding and T1 Substaging in Urothelial Bladder Cancer
Assiut University
BladMetrix
Oslo University Hospital
ENAiBLE
Photocure
MiLUT
University of Zurich
The Guiding Value of Liquid Biopsy Based on Urinary Tumor DNA/RNA in the Second Transurethral Resection of High-risk Non-muscle Invasive Bladder Cancer
Tianjin Medical University Second Hospital
ABLE-41
Ferring Pharmaceuticals
Urine-based Molecular Testing vs Cystoscopy for Surveillance of Nonmuscle Invasive Bladder Cancer (NMIBC)
Mayo Clinic
BLCCR
Photocure
ALU
Hopital Foch
Mood Alterations in the Patients With Non-Muscle Invasive Bladder Cancer Treated With BCG
Johns Hopkins University
Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)
University of Texas Southwestern Medical Center
Observational Clinical Study on High - Risk NMIBC Patients Choosing Trimodality Bladder - Sparing Therapy
Peking University First Hospital
Trop2-targeting NIR-II Molecular Probe for Guided Identification of Non-Muscle-Invasive Bladder Cancer
Yunnan Cancer Hospital
A Multicenter Prospective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Microscopic Residual Disease (MRD)
Peking University First Hospital
Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER
AstraZeneca
EVALUATION
Pharmalink
ProCaB
Universitaire Ziekenhuizen KU Leuven
The Prognostic Impact of Tumor Location in Non-Muscle-Invasive Bladder Cancer Patients
Huazhong University of Science and Technology
Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer
Wroclaw Medical University
START
University of Trieste
Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK.
IRCCS San Raffaele
RESECT
British Urology Researchers in Surgical Training
Analytical Specificity of Bladder EpiCheck Test in Healthy Population and Urology Patients Without Prior History or Evidence of Bladder Cancer
Nucleix Ltd.
URODYN
Aarhus University Hospital
ANTICIPATE X
Cepheid
A Performance Evaluation Study of Arquer's MCM5 Elisa Test (ADXBLADDER) to Aid in the Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer
Arquer Diagnostics Ltd
Antegrade Observational Comparative Study for the Intravesical Instillation Therapy of Bacillus Calmette Guerin With the Use of Different Types of Urinary Catheters in Patients With Urinary Bladder Cancer
National and Kapodistrian University of Athens
OPTIMA
Aarhus University Hospital
Machine Learning-Based Prediction of BCG Response in High-Risk Non-Muscle Invasive Bladder Cancer Patients
Mansoura University
The Effect of Post-voiding Reisdual Urine on Non-muscle Invasive Bladder Cancer Recurrence and Progression
Istanbul Medeniyet University
Evaluation of a Patient-Reported Symptom Index for NMIBC
University of Sydney
Validation of a Urine-based Assay With Genomic Markers for Predicting Recurrence for Non-muscle Invasive Bladder Cancer
Genomic Health®, Inc.
IMMUN VESSIE
University Hospital, Bordeaux
BUCEAH
Recep Tayyip Erdogan University Training and Research Hospital
ProCSUCaB
Universitaire Ziekenhuizen KU Leuven
Assessment Of Bladder Tumors Stage And Grade By Outpatient Flexible Cystoscopy Performed By Urology Resident
Mansoura University
A New Prognostic Model for Predicting the Outcome of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)
Mansoura University
A Prospective Registry to Assess the Effectiveness and Local Tolerability of Intravesical Valrubicin in Subjects With Non-muscle Invasive Bladder Cancer (NMIBC)
Endo Pharmaceuticals
Retrospective Chart Review of Valstar
Endo Pharmaceuticals